dev, Author at FOCUS - Page 7 of 27

FOCUS Enterprise-Focused Telecom Technology Quarterly – Spring 2021

FOCUS Enterprise-Focused Telecom Technology Quarterly – Spring 2021

dev2024-01-22T11:00:17+00:00May 18, 2021|Downloads, Industry Reports, Telecom Technologies & Services|

Public Markets

The FOCUS Enterprise-Focused Telecom Technology Index (EFTTI) cooled off significantly this past three months but still managed to turn in a positive return of 2.2%. This lagged both the 12.6% gain in the S&P 500 and the 6.8% gain in the NASDAQ by fairly wide margins.The sector is still up a hefty 48.4% over the past year, which puts its performance roughly in the middle of the 43.6% gain in the S&P 500 and the 57.1% gain in the NASDAQ over the corresponding time frame. Sector multiples are also significantly higher than they were a year ago. The sector revenue multiple jumped from 4.0x to 6.3x, while the sector EBITDA multiple increased from 16.0x to 24.6x.

FOCUS Investment Banking Strengthens Team With New Marketing Leadership

FOCUS Investment Banking Strengthens Team With New Marketing Leadership

dev2024-02-12T23:33:14+00:00May 17, 2021|Mergers & Acquisitions News, Mergers, Acquisitions & Divestitures, Team|

Washington, DC, (May 17, 2021) — FOCUS Investment Banking, a national middle market investment banking firm providing merger, acquisition, divestiture, and corporate finance services, announced today that Kahla Cooper and Amanda Damato have joined the firm as Director of Marketing and Marketing Manager, respectively.

FOCUS U.S. Communications Service Provider Quarterly: Spring 2021 Report

FOCUS U.S. Communications Service Provider Quarterly: Spring 2021 Report

dev2024-01-22T11:00:15+00:00April 27, 2021|Downloads, Industry Reports, Telecom Technologies & Services|

Public Markets

The FOCUS Communications Service Provider Index (CSPI) had a fourth straight reporting period with a positive return. However, this period’s gain of 1.3% was relatively modest and under-performed both the 5.8% gain in the S&P 500 and the 2.8% gain in the NASDAQ over the corresponding time frame. The CSPI is also up 27.6% for the full year. However, even with this substantial increase the sector still lags the S&P 500 (up 53.7%) and the NASDAQ (up 72.0%) by a wide margin. Sector multiples are significantly higher than they were at this time last year. The sector revenue multiple increased from 2.5x to 3.0x, and the sector EBITDA multiple jumped from 7.2x to 8.5x

FOCUS Telecom Business Services Quarterly: Spring 2021 Report

FOCUS Telecom Business Services Quarterly: Spring 2021 Report

dev2024-01-22T11:00:15+00:00April 20, 2021|Downloads, Industry Reports, Telecom Technologies & Services|

Public Markets

The FOCUS Telecom Business Services Index (TBSI) had a fourth straight reporting period with a positive return, marking a full year of positive returns since the outbreak of the pandemic. This past three months was particularly strong as the sector’s gain of 20.1% handily outperformed both the 5.8% gain in the S&P 500 and the 2.8% gain in the NASDAQ. For the full year, the TBSI is up a very impressive 63.0%. While this gain was good enough to give it a comfortable lead over the 53.7% year-over-year increase in the S&P 500, it still lagged the 72.0% gain in the NASDAQ, Sub sector multiples are also meaningfully higher than they were at this time last year.The sub sector revenue multiple jumped from 0.5x to 0.7x, while the EBITDA multiple spiked from 6.6x to 9.3x.

Behavioral Health Report – Q1 2021 Acquisition Activity and Outlook

Behavioral Health Report – Q1 2021 Acquisition Activity and Outlook

dev2024-02-12T22:57:12+00:00April 6, 2021|Behavioral Health, Healthcare|

Transaction Volume Continues to Increase Across Behavioral Health

The first quarter of 2021 delivered 38 reported behavioral health transactions, an increase over any quarter in 2020. We expect some of this activity reflects deals that were delayed due to COVID-19. However, we generally expect high deal flow throughout 2021, supported by increasing private equity interest, a favorable government, and a seller pool that is ready to transact.

Dermatology Report – Q1 2021 Acquisition Activity and Outlook

Dermatology Report – Q1 2021 Acquisition Activity and Outlook

dev2024-02-12T22:57:14+00:00April 6, 2021|Dermatology, Healthcare|

Core Dermatology Buyers Remain Active to Start 2021. Window of Opportunity May Be Starting to Close for Smaller Practices.

The first quarter of 2021 delivered five reported dermatology practice acquisitions. This activity decline may signal that the window of opportunity for small practice deals may be starting to close. Indeed, dermatology consolidation is now in its tenth year. However, Schweiger, Epiphany, and Anne Arundel continued to acquire smaller add-on practices and grow their platforms.

ENT & Allergy Report – Q1 2021 Acquisition Activity and Outlook

ENT & Allergy Report – Q1 2021 Acquisition Activity and Outlook

dev2024-02-12T22:57:15+00:00April 6, 2021|ENT & Allergy, Healthcare|

Private Equity Interest in ENT & Allergy Practices Accelerates. Expect Increasing Opportunity for Large Practice Sellers.

The first quarter of 2021 delivered five reported ENT practice acquisitions marking the most active three-month M&A period we have seen in the specialty. Notably, Audax Private Equity formally named its portfolio company “Elevate ENT” and expanded into Texas with the major acquisition of Texas ENT Specialists. While the next quarter may not produce as many deals, activity should remain high throughout this year.

Gastroenterology Report – Q1 2021 Acquisition Activity and Outlook

Gastroenterology Report – Q1 2021 Acquisition Activity and Outlook

dev2024-01-22T11:00:24+00:00April 6, 2021|Gastroenterology|

As Predicted, Gastroenterology Acquisition Activity Surges to New High in Q1 2021 – Major Opportunity for Selling Physicians

The first quarter of 2021 delivered nineteen gastroenterology practice acquisitions, marking an enormous surge of M&A activity within the specialty. To put that into context, the past three months had more acquisitions than the entire year of 2020. We expect that higher level of activity to continue as GI moves through the expansion lifecycle stage.

Home Health and Hospice Report – Q1 2021 Acquisition Activity and Outlook

Home Health and Hospice Report – Q1 2021 Acquisition Activity and Outlook

dev2024-01-22T11:00:24+00:00April 6, 2021|Home Health & Hospice|

Transaction Volume Continues to Increase Across Home Health & Hospice. Heaviest Activity in the West and Southwest.

The first quarter of 2021 delivered 35 reported home health and hospice transactions. We expect some of this activity reflects deals that were delayed due to COVID-19, however the pandemic generally increased attention on the sector. We expect high deal flow throughout 2021, supported by strong private equity interest, a favorable government, and a seller pool that is ready to transact. Transactions in the West and Southwest dominated the landscape.

Ophthalmology Report – Q1 2021 Acquisition Activity and Outlook

Ophthalmology Report – Q1 2021 Acquisition Activity and Outlook

dev2024-01-22T11:00:24+00:00April 6, 2021|Ophthalmology|

After a Strong First Quarter, 2021 Is Now Looking Like a True Window of Opportunity for Ophthalmology Deals

The first quarter of 2021 delivered fifteen reported ophthalmology practice acquisitions, continuing the surge of M&A activity within the specialty. Notably, EyeCare Partners, now owned by Partners Group, acquired Blue Sky Vision from Sterling Partners, marking a recapitalization of the Michigan-based platform. Acquisitions were spread across ten different buyers highlighting the competitive landscape and various choices practices have for potential partners.

About dev

Public Markets

Public Markets

Public Markets

Transaction Volume Continues to Increase Across Behavioral Health

Core Dermatology Buyers Remain Active to Start 2021. Window of Opportunity May Be Starting to Close for Smaller Practices.

Private Equity Interest in ENT & Allergy Practices Accelerates. Expect Increasing Opportunity for Large Practice Sellers.

As Predicted, Gastroenterology Acquisition Activity Surges to New High in Q1 2021 – Major Opportunity for Selling Physicians

Transaction Volume Continues to Increase Across Home Health & Hospice. Heaviest Activity in the West and Southwest.

After a Strong First Quarter, 2021 Is Now Looking Like a True Window of Opportunity for Ophthalmology Deals